Tenet Healthcare surges on Q2 earnings beat, lifts full-year guidance
Tenet Healthcare reported an earnings surprise that exceeded market expectations in its second-quarter earnings announcement and raised its annual guidance.
With positive earnings news, a 7-day increase of 8.3% and a 1.47 times increase in trading volume have been confirmed, indicating strong buying appeal. However, as the current price is near the resistance level of $250.0 and the moving average alignment has not yet been completed, we will consider entering while managing risk based on the support level of $220.0.
In the past 7 days, the stock has surged by 8.3% with trading volume increasing by 1.47 times. However, since the moving average alignment is not yet complete, I will adopt a strategy of approaching the stock after confirming the support level at $220.0. If the support level of $220.0 breaks, I will cut my losses, and if it reaches the resistance level of $250.0, I will take profits.
The RSI(14) is at 46.0, indicating a neutral level, and the moving averages have not yet completed a bullish alignment. The trading volume has increased to 1.47 times the 20-day average.
The assessment of the upward trend based on positive earnings news and increased trading volume was accurate; however, we underestimated the strength of the trend, recording a return of 10.9%, significantly exceeding the target return of 3.5%. Despite the technical uncertainty of an incomplete bullish arrangement, we confirmed that strong momentum drove the stock price.
Even if the moving average lines have not yet completed a bullish arrangement, we recognize that strong performance and accompanying trading volume can lead to a significant trend breakout. We will consider a strategy to flexibly manage profit-taking levels in the event of a sustained trend.